420 with CNW — Study to Survey Health-Care Workers, Obtain Input on Medical Marijuana

A study that will involve acquiring input on healthcare workers’ experience with medical marijuana and advice on the same was recently announced. The study, which will involve experts from the University of Massachusetts’ Dartmouth Charlton College of Business, Medicinal Genomics and the Cannabis Center of Excellence Inc. (“CCOE”) will focus on health-care workers in both Canada and the United States.

The study will gather information on the experiences of health-care providers with medical marijuana in their practices and the interest they may have in future clinical education associated with medical marijuana.

Cannabis Center of Excellence Inc. president Dr. Marion McNabb highlighted that approaches to incorporate medical marijuana use, along with knowledge of the risks and benefits of medical marijuana and the endocannabinoid system’s basics weren’t part of the regular curriculum for the majority of the health professionals. This includes those in emergency medicine, addiction and recovery, public health, dental, nursing and medical.

As more evidence on the effectiveness of marijuana is unearthed, the study’s objective is to hear from health-care providers on how the use of marijuana can be incorporated into their practices. In addition to this, the study will also focus on what health-care providers want to know about medical marijuana and what they do know.

A study that was published in 2019 discovered that more than 58% of health-care providers were of the opinion that medical marijuana was a legitimate medical therapy. The authors of the study noted that for provider concerns to be addressed, accurate information on the potential for drug interactions needed to be spread.

A separate study noted that standardized education would make sure that health-care providers were prepared to promote the responsible use of marijuana if it had been indicated for medically appropriate conditions and symptoms.

Despite the advances made though, more is still required. Earlier in April, a study conducted in Israel found that Israeli medical students felt unprepared despite the fact that they were more supportive of the use of medical marijuana to manage pain, in comparison with their counterparts in Thailand.

The CCOE also revealed that the study, which is backed by the Super Critical Labs, has been approved for human research by the Dartmouth Institutional Review Board. It also noted that the anonymous survey, which would be available from May 2021 to May 2022, would take roughly 12 minutes for health-care providers to complete.

McNabb, who is the chief investigator, will be joined by 15 other researchers, including veterans, clinicians and other scientists. The body expects that initial study results will be available by October 2021.

As a growing amount of more marijuana research is done by independent entities, the products made by sector players such as Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are likely to gain more acceptance from the medical community since the products will be better understood by that segment.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Releases Q1 2021 Financial Numbers, Chooses SRAX Inc. (NASDAQ: SRAX) as Communications Partner

Grapefruit USA (OTCQB: GPFT), a California-based cannabis company, has partnered with SRAX Inc. (NASDAQ: SRAX), an investor relations and communications marketing firm, to strengthen its brand and product line as well as increase awareness of its new e-commerce site and related affiliate program. In the announcement Grapefruit cited SRAX’s novel data-driven approaches to marketing and the company ability to create awareness of stock as key factors in its decision. In addition, the company has filed its quarterly report for the period ended March 31, 2021. The report included disappointing numbers for the company, including net revenues of $350,815, a decrease of 10% over revenues of $393,559 for the three months ended March 31, 2020. In the announcement, the company pointed to a strong cannabis harvest in fourth-quarter 2020 and early 2021 cannabis as a contributing factor behind the reduction in revenues, noting that the harvest drove down wholesale cannabis prices and limited the profitability of GPFT’s distribution and trading operations. As a result, Grapefruit limited distribution and trading efforts, focusing more on improving upon and launching its Hourglass products. The company anticipates those efforts will result in significantly higher Hourglass-related revenues through the remaining quarters of 2021 and into 2022. GPFT also expects is newly launched ecommerce site and affiliate program to fuel the company’s revenues moving forward. “We are obviously dissatisfied with the small revenue decrease year over year for the first quarter,” said Grapefruit CEO Bradley J. Yourist in the press release. “However, we adjusted by decreasing our less-profitable distribution and trading activities, which we can switch on at a moment’s notice when the seasonal aspect of the wholesale cannabis business adjusts, and profitable distribution and trading opportunities present themselves during the remainder of the year as they inevitably do. Furthermore, as our wholesale and retail Hourglass THC/cannabinoid and THC-free hemp derived CBD products sales take off in the remainder of 2021 and beyond, the increased revenues they generate will mitigate the overall revenue impact of the seasonality of the distribution and trading operations. Getting to that point as quickly as possible is one of our primary goals, and as we always do, we will attain it in the near future.”

To view the full press releases, visit https://cnw.fm/nwdXd and https://cnw.fm/cfWU9

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Missouri Court Rules That Medical Cannabis License Applications Aren’t Secret

Medical marijuana license applicants in Missouri were offered a much-needed reprieve after an appeals court ruled that state regulators cannot keep information from medical cannabis applications secret. In 2018, voters approved a constitutional amendment that legalized medical marijuana, making Missouri the 33rd state to legalize medical cannabis. Soon after, hundreds of business owners who saw a solid business opportunity applied for business licenses for everything from growing and distributing to selling cannabis, and chaos soon ensued.

More than 820 companies were denied licenses. Those companies asked an administrative hearing commission to look into the scoring system used to score candidates, claiming that it was flawed and unfair. Health and Senior Services (“DHSS”), which was tasked with overseeing the license application process, scored more than 1,700 candidates, ultimately awarding state licenses to 60 cultivators, 86 infused manufacturers, 11 testing facilities, 192 dispensaries and 22 transporters.

Consequently, Kings Garden Midwest, a California-based company that had sought and failed to acquire a cannabis cultivation license, filed a lawsuit against the state claiming that the scoring process used to grade applicants was “arbitrary and capricious.” Applicants would be awarded different points for the same or similar answers, and Kings Garden wanted to go over the information on other applications to see if the scoring was actually fair. The court agreed with Kings Garden, stating in a precedent-setting ruling that the information on application licenses could not be kept secret.

Since applications are ranked competitively against each other rather than solely on their own merits, the court wrote, comparing the information in these applications was the only way to find out if the Kings Garden’s application was scored in an “arbitrary or capricious manner.” According to the court, keeping this information from companies seeking to prove whether or not the scoring system was flawed is “unreasonable and absurd.” However, the DHSS, which outsourced the application scoring process to a private company, argued that the constitutional amendment that legalized medical marijuana in the state requires that such information remains confidential.

Lisa Cox, a DHSS spokesperson, says that the department is planning on appealing the ruling at the Supreme Court. Missouri’s licensing process has been upheld by numerous legal challenges, and Greg Wu, co-chair of cannabis law practice group Hardy & Bacon law states that the state will see quite a number of lawsuits regarding medical marijuana applications. Lyndall Frankel, the DHSS’ top cannabis regulator, says that the health department expects to spend at least $12.4 million fighting these suits.

The campaign to accord the cannabis industry equal treatment is likely to notch a win if the DHSS loses its planned appeal to the state Supreme Court. If that happens, the entire sector, including companies such as Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE: CHAL) (OTCQB: GLDFF), could regard that as just another step forward, and the push for an improved operational environment for the industry will continue.

NOTE TO INVESTORS: The latest news and updates relating to Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE: CHAL) (OTCQB: GLDFF), are available in the company’s newsroom at https://cnw.fm/GLDFF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Worldwide Increases in Lumber Prices Could Boost the Hemp Industry

Talk about construction and you inevitably end up talking about lumber. Lumber has for long been a popular and essential construction material, with concrete taking pole position on the most popular material list. Everything from houses, bridges and even wagons have been fashioned out of wood, and each culture has its own unique products made from wood. However, all that is now being threatened by the skyrocketing price of lumber, and hemp may come to the rescue.

Visit any lumberyard to buy pieces of timber, and chances are you will suffer a case of sticker shock. Using data from NASDAQ as a case in point, the price of lumber almost tripled in 2020. Fortunately for the global construction industry, an ecofriendly alternative to lumber exists: hemp.

Interestingly, most people immediately think of cannabidiol (“CBD”) when hemp is mentioned. This is because the past couple of years has seen interest in CBD skyrocket, and most CBD is extracted from hemp since hemp is federally legal because it has only miniscule quantities of THC, the compound which makes users of marijuana high. Hemp and marijuana belong to the same cannabis family.

Some people are aware that clothing, rope and paper can also be processed from hemp. However, another application of hemp — using it as a construction material — is likely to grow in popularity partly as a result of the rate at which lumber prices are rising.

For starters, the woody fibers found inside the hemp plant can be processed into hemp boards. These boards are similar to the boards made from wood. Hemp can also be made into “hempcrete,” an ecofriendly alternative to concrete. Hempcrete has a number of benefits, including its resistance to pest attacks and superior fire resistance. As awareness grows about these benefits, more people will choose this material over the traditional construction materials in current use.

A barrier that has kept hempcrete in the realm of niche construction materials has been its relatively high cost. However, as the price of lumber inches upward, a point will be reached when parity is attained with regard to the cost of these two materials. At that point, the use of hempcrete is likely to explode as cost will no longer be a barrier.

Considering the fact that hemp grows rather fast, it isn’t hard to imagine that as its use as a construction material becomes widespread, economies of scale will kick in, and the material may become a material of choice in years to come.

As the uptake of hemp in the construction sector grows, cannabis industry actors such as Grapefruit USA Inc. (OTCQB: GPFT) could see another revenue stream open up from the fibrous residue after CBD and other cannabinoids have been extracted from hemp dry matter.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Connecticut Legislators in Discussions with Governor about Marijuana Legalization

Gov. Ned Lamont will be meeting lawmakers in his office in the coming week to finalize negotiations on a plan to legalize cannabis in the state of Connecticut. A recent poll shows that the majority of voters in the state support the change in policy.

Enacting the reform, which has been an objective of various legislators as well as Lamont’s administration, has become a top priority now that the legislative session will be coming to a close less than a month from now.

Several meetings on the issue have been held to decide what a legal marijuana market should look like. Despite this, however, there are still a few things that need to be resolved. House Majority Leader Jason Rojas said that negotiations were currently focusing on the eligibility criteria to be used for social equity applicants. Any individual who could qualify as such would be afforded benefits in the process of marijuana business licensing.

Earlier this month, Matt Ritter, the House Speaker, stated that the legislature was open to discussing the issue during a special session in an attempt to sort out the differences between the legalization initiatives that had been presented by Lamont and legislators.

Marijuana advocates in the state are pleased with the discussions being conducted, with CURE CT policy director Jason Ortiz noting that it was encouraging to see legislators focusing on working to get things right. CURE CT is an advocacy group that supports the legalization of marijuana. Ortiz is also part of the legalization group assembled by the governor, which gave recommendations on social equity.

The aforementioned poll, which was conducted by the Sacred Heart University, shows that of the state’s residents, 64% are in favor of the legalization of adult use marijuana. Additionally, 62% of those who responded to the poll stated that they were in favor of the expungement of previous marijuana convictions while another 76% were of the opinion that cannabis had fewer effects than alcohol.

The survey was conducted between April 20 and 26, 2021, and involved 1,000 residents in the state. Its results are consistent with past poll results on cannabis legalization.

Earlier in April, a measure to legalize adult use cannabis that was presented as part of the budget by Lamont was approved by the Judiciary Committee after a few amendments were made by the panel. Lamont revealed that if the initiative wasn’t enacted in 2021, it would be brought before voters on the state’s 2022 ballot.

It is good to see legislators and the governor doing their best to ensure that cannabis policy reform takes place. Such occurrences may offer hope to marijuana industry players such as Canada-based Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) that their US-based counterparts will one day have nearly uniform cannabis regulations governing all states as is the case across the border in Canada.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are available in the company’s newsroom at http://cnw.fm/PACR

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Poll Shows Mississippi Voters Favor Impeaching Justices Who Voided Medical Marijuana Measure

A majority of Americans support legalizing cannabis, at least for medical purposes, and the numbers show it. In Mississippi, for instance, voters approved a ballot initiative to legalize medical marijuana in the state. The win was, however, overturned by the state Supreme Court after a city mayor filed a legal challenge against the citizens’ initiative, arguing that it violated procedural rules laid out by the constitution.

According to a poll undertaken shortly after the ruling went public, Mississippi voters are in favor of impeaching the judges who overturned the medical marijuana ballot initiative. Mississippi-based Chism Strategies, which had provided help to supporters of the now-void voters’ initiative, conducted the study. The company found that 60.9% of Mississippi voters were against the Supreme Court’s decision to overturn the initiative and entirely do away with the process of gathering signatures to allow voters to decide issues at the ballot.

Only 22% of the respondents supported the ruling while 59.6% felt that Miss. Governor Tate Reeves should call a special session to discuss medical marijuana. The thought of holding such a session has been on many people’s minds since the ruling, with inside sources saying that some lawmakers have already mentioned the issue to the governor’s office. House Speaker Phillip Gunn has voiced his support for a special session, stating that he believes that voters have the right to use the referendum and initiative process as it gives them a direct say in public policy issues.

More than 69% of the Mississippi residents polled had voted in favor of the medical cannabis initiative while 25.2% voted against it. The poll, which was conducted over mobile with landline and cell phone users, had a marginal error of 3.26%. According to Brad Chism from Chism Strategies, support for the medical cannabis ballot initiative was bipartisan with both Republicans and Democrats reacting with shock to the Supreme Court’s decision.

In fact, 52% of those polled revealed that they were “much” or “somewhat” less likely to vote for a lawmaker who supported legalizing medical marijuana in the state while under 30% were “much” or “somewhat” more likely to support a candidate who opposed medical marijuana. Additionally, 69.7% of Mississippi voters supported the idea of the legislature allowing a medical cannabis program similar to the one initiated by the voter-passed ballot initiative.

The decision to overturn the 2019 ballot initiative came after Mary Hawkins, mayor of the city of Madison, filed a lawsuit alleging that some procedural rules for placing measures on the ballot had been violated. The Supreme Court obliged and voided the medical marijuana initiative.

Cannabis industry actors such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) may empathize with the voters in Mississippi who saw their ballot decision go up in smoke on a technicality.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Distribution Agreement to Expand TRACE Products

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness, beverage and natural products company, has finalized an agreement with Benefit Holdings LLC, dba Benefit Brand Management. Benefit Brand Management is a leading brand management company, and the contracts calls for Benefit to distribute BevCanna’s line of TRACE-branded products to U.S. retailers, starting in New York and Chicago, and also including the state of California. The contract will be enacted through BevCanna’s previously announced agreement with Riviera Beverages and is designed to speed up the expansion of the Naturo Group portfolio of market-leading ancient organic mineral beverages. Active in the food and beverage space for more than two decades, Benefit Brand Management focuses on natural and organic products. The company has assisted in the launch of several well-known brands in the space, including Kimnori, Hey Aloe, Pulp Story Juice and Cauli Crunch, a cauliflower-crumb breading product. “With demand for wellness-focused beverages rapidly increasing among U.S. consumers, this is the ideal time to introduce the TRACE brand to a whole new demographic,” said BevCanna president Melise Panetta in the press release. “We’re very excited to work with Benefit on launching the brand, capitalizing on their extensive network and detailed knowledge of the natural products retail landscape in the U.S.”

To view the full press release, visit https://cnw.fm/hAKK4

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210 million bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, please visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Minnesota Legislators Vote to Expand State Medical Marijuana Program

Legislators in the state of Minnesota recently voted to allow the expansion of its medical marijuana program, which will permit patients to smoke the dried flower.

The state of Minnesota has allowed the use of medical marijuana since May 2014 when then-Gov. Mark Dayton signed into law a legislation that legalized cannabis for the treatment of several medical ailments, including Crohn’s disease, ALS, Tourette’s syndrome, glaucoma, HIV/AIDS, epilepsy and cancer. Despite this, it only permitted the use of the plant in pill, oil and liquid forms.

Medical marijuana activist Patrick McClellan stated that this latest move was an important change. He noted that it would also make it easier for him to afford the medication, as the cost of liquid marijuana was on the higher side. McClellan suffers from a rare form of muscular dystrophy and uses marijuana to manage it.

Maren Schroeder, who also uses medical marijuana, revealed that she had to part with $250 every month for medical marijuana and noted that she was excited to have the smokable option. She explained that this was because she could obtain the plant legally, adding that this meant that the product she would consume had been tested in labs and wasn’t contaminated with herbicides, pesticides or mold.

The state’s allowing the use of the unprocessed marijuana plant is also expected to decrease the cost for patients in the medical marijuana program, which will make the product more accessible.

Senate Health and Human Services Committee chair Sen. Michelle Benson asserted that the change would help many patients. During a debate in the Senate earlier this week, Benson had explained that the committee’s objective was to make the plant available to individuals with a medical need who couldn’t afford it.

The medical marijuana law is scheduled to take effect once a system for testing the dried raw marijuana from the existing manufacturers in the state has been established, or by March 1 next year.

Ryan Winkler, the DFL House majority leader who backed the full-legalization effort, heralded the medical marijuana change. He stated that by allowing the use of dried raw marijuana, which was cheaper to produce, the cost of existing products would decrease.

However, not everyone seemed to be on board with the idea. For instance, Rep. Tim Miller opposed the medical marijuana provision in the House, claiming that the move wasn’t entirely honest and hadn’t gone through the right channels.

As the state’s medical cannabis program expands, patients and the entire state will benefit in the same way as the states that have enacted laws deemed relatively investment-friendly for operators such as Hero Technologies Inc. (OTC: HENC). The more operators a state has, the more competitively priced cannabis products are likely to be.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Alabama Governor Appends Signature to Medical Cannabis Legalization Bill

Medical marijuana patients in the state of Alabama have something to be happy about after Governor Kay Ivey signed a medical cannabis bill that was sent to her desk last month after gaining the Legislature’s approval. The bill, which had cleared two House Committees before heading to the Senate for its final approval, was sponsored by Senator Tim Nelson. On top of allowing patients with qualifying conditions to access medical marijuana, the bill would also establish a commission to oversee licensing and implement the regulations for the state’s medical cannabis program.

When the legislation first hit Ivey’s desk, she said she hoped to sign it after doing a thorough review of its provisions. While she was aware of cannabis’ purported health benefits, she still had some misgivings and didn’t want the situation to get out of control. A spokesperson from her office said that medical marijuana was an emotional and sensitive issue that was dear to many people’s hearts, and the governor would give it the diligence it deserves.

Rather than propose line-item amendments as some lawmakers thought she may, Ivey signed bill SB 46 into law as is. In a press statement, she reiterated that medical marijuana is a sensitive and emotional issue and that signing the bill was a significant first step. She was especially interested in marijuana’s ability to help individuals with chronic illnesses and those who are suffering from terminal conditions. Ivey acknowledged that a lot more research is required and that the state will continue studying and researching to ensure it runs a safe, productive and responsible medical marijuana program.

Although the bill that Ivey signed into law is pretty restrictive in comparison to other state medical marijuana programs, it is certainly better than nothing. Patients suffering from one of twenty qualifying conditions, including post-traumatic stress disorder (“PTSD”), intractable pain, sleep disorders, and anxiety, will be granted access to medical cannabis. However, regulators would not be able to independently add to the list of qualifying conditions; this decision will be left to lawmakers.

Additionally, SB 46 doesn’t allow raw cannabis flower, smoking, vaping and cannabis-infused baked goods. Patients will be restricted to oils, lozenges, capsules, topical patches and suppositories. Physicians would be required to take a four-hour continuing course and pass an exam to be able to recommend medical cannabis to their patients. The course would cost more than $500, and physicians would have to retake it every two years.

Now that Alabama is easing some of its most stringent restrictions regarding the scope of the medical marijuana program, the state is on course to close the gap, from a regulatory standpoint, with more mature markets where entities such as Sonoma Biologics Corp. operate.

NOTE TO INVESTORS: The latest news and updates relating to Sonoma Biologics Corp. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces White Label Agreement with BC-Based FLO Brands

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has signed a customer manufacturing/white label agreement through its wholly owned subsidiary, Pure Extracts Manufacturing Corp. The agreement, which is with boutique brand house FLO Brands Inc., involves a partnership to launch a line of cannabis vape products. FLO Brands is dedicated to creating state-of-the-art, cannabis-based products using BC’s finest genetics. The agreement between Pure Extracts and FLO Brands outlines the initial production of 3 SKUs of 0.5 gram, 510 vape cartridges. These exclusive products will be manufactured using Pure Extracts’ 30-plus proprietary formulations. In addition to co-manufacturing the products, Pure Extracts will be providing all sales and distribution services, including labelling, packaging, applying of excise stamps and shipping. “We are excited about launching a white label product with our new partner, FLO Brands, a fellow BC company,” said Pure Extracts CEO Ben Nikolaevsky. “They have enormous capacity to create new cannabis products as the market matures here in Canada and consumer tastes evolve. With the addition of FLO and the increased capacity and flexibility our new cosolvent injection system provides, we have begun to execute our strategy with craft producers and branding specialists to get their white label products into the provincial dispensaries and drive up to $3 million of annual revenue from this vertical.”

To view the full press release, visit https://cnw.fm/nOZQP

About Pure Extracts Technologies Corp.

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On Sept. 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act. In addition, the company’s stock began trading on the Canadian Securities Exchange (“CSE”) on Nov. 5, 2020. For more information about the company, please visit www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://cnw.fm/PULL

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com